7Economy

Global Stocks Library

Sino Biopharmaceutical (1177.HK) risk is overstated

February 21, 2012 wh1001 Asia

Sino Biopharmaceutical (1177.HK) risk is overstated

Sino Biopharmaceutical (1177.HK) risk is overstated

Related content:

  1. Sino Biopharmaceutical Limited (1177.HK) better indicator to watch for growth
  2. Tencent Holdings (0700.HK) potential downside risk
  3. Preuksa Real Estate (PS.BK) balance sheet remains at risk
  4. Shin Kong Financial Holding (2888.TW) risk to EV on the rise
  5. Toyota Motor (7203.JP) Raise forecasts on expectations
  6. Yahoo Japan (4689.JP) new executive structure
  7. GWA Group (GWA.AX) Federal Government Ceases Renewal Energy Bonus
  8. Dainippon Sumitomo Pharma (4506.JP) Brings in anticancer stem cell treatments
  9. CSL Ltd (CSL.AX) November PPTA Data
  10. ARB Corp Ltd (ARP.AX) five reasons why we like.pdf
Share

Comments are currently closed.

Follow 7Economy on Twitter

 

May 2012
M T W T F S S
« Mar    
 123456
78910111213
14151617181920
21222324252627
28293031  

Categories

Archives

7Economy